We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current OPRX market cap is 181.16M. The company's latest EPS is USD -0.6301 and P/E is -15.84.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 13.98M | 15.09M | 19.65M | 13M | 13.82M |
| Operating Income | -4.15M | -3.76M | -1.64M | -7.06M | -4.88M |
| Net Income | -3.89M | -3.47M | -325k | -6.4M | -4.16M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21.21M | 24.6M | 43.31M | 61.29M | 62.45M |
| Operating Income | 180k | -3.69M | -2.14M | 361k | -12.29M |
| Net Income | 226k | -3.14M | -2.21M | 378k | -11.44M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 147.45M | 135.87M | 134.65M | 131.69M | 121.33M |
| Total Liabilities | 6.63M | 6.3M | 8.54M | 7.73M | 5.51M |
| Total Equity | 140.82M | 129.57M | 126.11M | 123.96M | 115.82M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 25.06M | 56.64M | 60.33M | 140.99M | 134.65M |
| Total Liabilities | 6.6M | 11.78M | 10.35M | 9.61M | 8.54M |
| Total Equity | 18.46M | 44.86M | 49.97M | 131.38M | 126.11M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 4.39M | 7.85M | 10.65M | -86k | -2.46M |
| Investing | -2.19M | -39.69M | -58.18M | -1.55M | 1.67M |
| Financing | 509k | -11.51M | -18.95M | -130k | -7.62M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 793k | -1.66M | -6.31M | 726k | 10.65M |
| Investing | -5.69M | -10.58M | -125k | -486k | -58.18M |
| Financing | 8.69M | 22.18M | -1.9M | 73.93M | -18.95M |
| Market Cap | 181.16M |
| Price to Earnings Ratio | -15.84 |
| Price to Sales Ratio | 2.9 |
| Price to Cash Ratio | 9.95 |
| Price to Book Ratio | 1.44 |
| Dividend Yield | - |
| Shares Outstanding | 18.15M |
| Average Volume (1 week) | 137.53k |
| Average Volume (1 Month) | 173.54k |
| 52 Week Change | -50.03% |
| 52 Week High | 20.13 |
| 52 Week Low | 6.92 |
| Spread (Intraday) | 5.05 (42.51%) |
| Company Name | OptimizeRx Corporation |
| Address |
400 water street rochester, minnesota 48307 |
| Website | https:// |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
